FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,167.79-0.13%
XLE56.790.04%
STOXX50E5,860.32-0.39%
XLF51.74-0.14%
FTSE10,321.09-0.56%
IXIC24,887.100.20%
RUT2,788.190.04%
GSPC7,173.910.12%
Temp29Β°C
UV7.3
Feels32.8Β°C
Humidity62%
Wind12.2 km/h
Air QualityAQI 1
Cloud Cover25%
Rain0%
Sunrise06:00 AM
Sunset06:47 PM
Time3:50 PM
DEFA14ASEC Filing

Alkermes plc. β€” DEFA14A Filing

April 6, 2026 at 12:00 AM

🧾 What This Document Is

This is a DEFA14A, which stands for "Definitive Additional Material" related to a proxy statement. Think of it as a "last call" reminder and voting guide for shareholders before a big vote.

It’s not the full proxy statement itself, but a supplemental notice summarizing the upcoming meeting and the proposals. It confirms the meeting details and gives shareholders the essential information they need to cast their votes.
πŸ‘‰ Why it matters: This is the final nudge to get shareholders to vote on important company decisions.

🏒 What The Company Does

Alkermes plc is a global biopharmaceutical company focused on developing medicines for central nervous system (CNS) diseases, such as addiction, schizophrenia, and bipolar disorder.

πŸ‘‰ In simple terms: They research and make drugs that help people with complex brain-related conditions.

πŸ“… Meeting Logistics & Key Dates

The 2026 Annual General Meeting of Shareholders is scheduled for:

  • Date: Wednesday, May 20, 2026
  • Time: 2:00 PM Irish Standard Time
  • Location: Alkermes plc offices, Connaught House, 1 Burlington Road, Dublin 4, Ireland.

Shareholders of record as of March 13, 2026, are entitled to vote.
πŸ‘‰ Why it matters: Only shareholders who owned stock on this "Record Date" get a say.

You can vote online until 11:59 PM Eastern Time on May 19, 2026 (that's 4:59 AM in Dublin on May 20).

πŸ“‹ The Proposals To Vote On

The Board of Directors is asking shareholders to vote on six items. They recommend a vote FOR all of them.

  1. Proposal 1: Elect Directors. Vote to elect nine individuals to the Board for one-year terms. This includes current leaders like CEO Shane M. Cooke and Richard F. Pops.
  2. Proposal 2: Approve Executive Pay. This is a non-binding "Say on Pay" vote on the compensation for the company's top executives.
  3. Proposal 3: Ratify the Auditor. Appoint PricewaterhouseCoopers LLP as the independent accounting firm and authorize the Board to set their pay.
  4. Proposal 4: Approve the Stock Plan. Approve amendments to the company's 2018 Stock Option and Incentive Plan.
  5. Proposal 5: Renew Share Allotment Authority. A standard item under Irish law, giving the Board permission to issue new shares.
  6. Proposal 6: Renew Pre-emption Rights Disapplication. Another technical Irish law proposal, allowing the Board to issue shares for cash without first offering them to existing shareholders.

πŸ’‘ Why This Matters: The Proposals Explained

Let's break down the real-world meaning of a few key proposals.

  • Proposal 1 (Directors): You're choosing the stewards who oversee the CEO and set the company's long-term strategy.
  • Proposal 2 (Executive Pay): While non-binding, this "shareholder voice" can pressure the board to align pay with performance.
  • Proposal 4 (Stock Plan): This is how the company attracts and retains talent by granting stock options. Approving it keeps an important tool in their HR toolbox.
  • Proposals 5 & 6 (Irish Law): These are routine for Irish-incorporated companies like Alkermes. They ensure the Board has the flexibility to manage the company's capital structure efficiently.

βš–οΈ Big Picture: Strengths & Risks

πŸ‘ Strengths (Based on this filing):

  • Routine Process: This is a standard, orderly annual meeting, which signals stable corporate governance.
  • Board Stability: The full Board is up for re-election, suggesting continuity and no sudden internal upheaval.
  • Clear Guidance: The Board’s unanimous "FOR" recommendations on all proposals simplify the decision for shareholders.

⚠️ Risks & Considerations:

  • "Say on Pay" Pressure: If shareholders vote against Proposal 2, it would be a strong signal of dissatisfaction with executive compensation, even if it's non-binding.
  • Market Context Missing: This filing alone doesn't provide business updates. Investors should look at the accompanying Annual Report (Form 10-K) for performance results and challenges.
  • Cross-Listed Complexity: As an Irish company, some procedures (like share authorities) may be unfamiliar to U.S. investors.

🧠 The Analogy

Think of the annual general meeting as a school's PTA annual election. The filing is the flyer that tells you when and where it is, lists the parents running for the board, and asks you to approve the annual budget and the bake sale fundraiser plan. You can vote by mailing in a slip ahead of time or show up in person.

🧩 Final Takeaway

This document is a procedural roadmap for Alkermes' 2026 shareholder vote. The key action is for shareholders to review and vote FOR the routine proposals, including the election of directors and auditor ratification, to ensure smooth corporate operations for the coming year. The most scrutinized item is likely the advisory vote on executive pay.